ID
12439
Beskrivning
Study documentation part: Relapse Evaluation Study short name: DIMAT MS Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. EudraCT - No.: 2014-003481-25. Clinical Trial No.r: NCT02461069. Please document clinically significant symptoms as Adverse Events on form Adverse Events. (and also additionally as SAE if a seriousness criterion is fulfilled). Please document all Medications which are administered to treat the relapse on form concomitant medication. Please document all Study Medication dose adjustments and interruptions on form study medication.
Nyckelord
Versioner (4)
- 2015-11-17 2015-11-17 - Julian Varghese
- 2015-11-17 2015-11-17 - Julian Varghese
- 2016-05-28 2016-05-28 -
- 2016-05-28 2016-05-28 -
Uppladdad den
17 november 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Relapse Evaluation DIMAT MS Multiple Sclerosis NCT02461069
Relapse Evaluation
- StudyEvent: ODM
Beskrivning
Treatment of Relapse
Beskrivning
no treatment
Datatyp
boolean
Beskrivning
Plasmapheresis / Immunoadsorption
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0398341
- UMLS CUI [2]
- C0032134
Beskrivning
enter number of cycles
Datatyp
integer
Beskrivning
other treatment
Datatyp
text
Alias
- UMLS CUI [1]
- C0087111
Beskrivning
Intravenous Steroid Treatment
Alias
- UMLS CUI-1
- C0149783
Similar models
Relapse Evaluation
- StudyEvent: ODM
C0808070 (UMLS CUI [1,2])
C0521091 (UMLS CUI [1,2])
C0521091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0032134 (UMLS CUI [2])